nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—type 2 diabetes mellitus—polycystic ovary syndrome	0.904	1	CtDrD
Sitagliptin—Viral diarrhoea—Metformin—polycystic ovary syndrome	0.00612	0.109	CcSEcCtD
Sitagliptin—Sinus headache—Metformin—polycystic ovary syndrome	0.0049	0.0871	CcSEcCtD
Sitagliptin—Sinus congestion—Metformin—polycystic ovary syndrome	0.00321	0.057	CcSEcCtD
Sitagliptin—Toothache—Metformin—polycystic ovary syndrome	0.00263	0.0466	CcSEcCtD
Sitagliptin—Contusion—Metformin—polycystic ovary syndrome	0.00183	0.0325	CcSEcCtD
Sitagliptin—DPP4—Peptide hormone metabolism—CGB5—polycystic ovary syndrome	0.00165	0.0633	CbGpPWpGaD
Sitagliptin—CYP3A4—urine—polycystic ovary syndrome	0.00147	0.11	CbGeAlD
Sitagliptin—DPP4—embryo—polycystic ovary syndrome	0.00146	0.109	CbGeAlD
Sitagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—TCF7L2—polycystic ovary syndrome	0.00143	0.0548	CbGpPWpGaD
Sitagliptin—DPP4—Incretin synthesis, secretion, and inactivation—TCF7L2—polycystic ovary syndrome	0.00127	0.0487	CbGpPWpGaD
Sitagliptin—DPP4—Peptide hormone metabolism—CPB2—polycystic ovary syndrome	0.00125	0.048	CbGpPWpGaD
Sitagliptin—Renal impairment—Metformin—polycystic ovary syndrome	0.00122	0.0216	CcSEcCtD
Sitagliptin—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00119	0.0211	CcSEcCtD
Sitagliptin—Pain in extremity—Metformin—polycystic ovary syndrome	0.00116	0.0206	CcSEcCtD
Sitagliptin—Migraine—Metformin—polycystic ovary syndrome	0.00114	0.0203	CcSEcCtD
Sitagliptin—DPP4—endometrium—polycystic ovary syndrome	0.00107	0.0797	CbGeAlD
Sitagliptin—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00106	0.0188	CcSEcCtD
Sitagliptin—Breast disorder—Metformin—polycystic ovary syndrome	0.00105	0.0186	CcSEcCtD
Sitagliptin—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00104	0.0184	CcSEcCtD
Sitagliptin—Influenza—Metformin—polycystic ovary syndrome	0.001	0.0178	CcSEcCtD
Sitagliptin—DPP4—uterus—polycystic ovary syndrome	0.000986	0.0734	CbGeAlD
Sitagliptin—Pancreatitis—Metformin—polycystic ovary syndrome	0.000983	0.0175	CcSEcCtD
Sitagliptin—DPP4—adipose tissue—polycystic ovary syndrome	0.000964	0.0718	CbGeAlD
Sitagliptin—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.000961	0.0171	CcSEcCtD
Sitagliptin—DPP4—Peptide hormone metabolism—INHBB—polycystic ovary syndrome	0.00095	0.0364	CbGpPWpGaD
Sitagliptin—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000931	0.0165	CcSEcCtD
Sitagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—LEP—polycystic ovary syndrome	0.000925	0.0354	CbGpPWpGaD
Sitagliptin—Infestation NOS—Metformin—polycystic ovary syndrome	0.000894	0.0159	CcSEcCtD
Sitagliptin—Infestation—Metformin—polycystic ovary syndrome	0.000894	0.0159	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000876	0.0156	CcSEcCtD
Sitagliptin—DPP4—adrenal gland—polycystic ovary syndrome	0.000865	0.0644	CbGeAlD
Sitagliptin—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.000845	0.015	CcSEcCtD
Sitagliptin—DPP4—Incretin synthesis, secretion, and inactivation—LEP—polycystic ovary syndrome	0.000823	0.0315	CbGpPWpGaD
Sitagliptin—DPP4—female gonad—polycystic ovary syndrome	0.000806	0.0601	CbGeAlD
Sitagliptin—DPP4—vagina—polycystic ovary syndrome	0.000801	0.0597	CbGeAlD
Sitagliptin—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000798	0.0142	CcSEcCtD
Sitagliptin—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00079	0.014	CcSEcCtD
Sitagliptin—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000788	0.014	CcSEcCtD
Sitagliptin—DPP4—endocrine gland—polycystic ovary syndrome	0.00075	0.0558	CbGeAlD
Sitagliptin—Eye disorder—Metformin—polycystic ovary syndrome	0.00075	0.0133	CcSEcCtD
Sitagliptin—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000744	0.0132	CcSEcCtD
Sitagliptin—CYP3A4—Benzo(a)pyrene metabolism—AKR1C2—polycystic ovary syndrome	0.000739	0.0283	CbGpPWpGaD
Sitagliptin—Angiopathy—Metformin—polycystic ovary syndrome	0.000728	0.0129	CcSEcCtD
Sitagliptin—Immune system disorder—Metformin—polycystic ovary syndrome	0.000725	0.0129	CcSEcCtD
Sitagliptin—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000723	0.0128	CcSEcCtD
Sitagliptin—DPP4—Peptide hormone metabolism—LHB—polycystic ovary syndrome	0.000702	0.0269	CbGpPWpGaD
Sitagliptin—Malnutrition—Metformin—polycystic ovary syndrome	0.000698	0.0124	CcSEcCtD
Sitagliptin—Flatulence—Metformin—polycystic ovary syndrome	0.000688	0.0122	CcSEcCtD
Sitagliptin—Muscle spasms—Metformin—polycystic ovary syndrome	0.000671	0.0119	CcSEcCtD
Sitagliptin—Vision blurred—Metformin—polycystic ovary syndrome	0.000658	0.0117	CcSEcCtD
Sitagliptin—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000648	0.0115	CcSEcCtD
Sitagliptin—Malaise—Metformin—polycystic ovary syndrome	0.00063	0.0112	CcSEcCtD
Sitagliptin—ABCB1—ABC-family proteins mediated transport—ABCB6—polycystic ovary syndrome	0.000614	0.0235	CbGpPWpGaD
Sitagliptin—Hypertension—Metformin—polycystic ovary syndrome	0.000603	0.0107	CcSEcCtD
Sitagliptin—Myalgia—Metformin—polycystic ovary syndrome	0.000594	0.0106	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00059	0.0105	CcSEcCtD
Sitagliptin—Discomfort—Metformin—polycystic ovary syndrome	0.000587	0.0104	CcSEcCtD
Sitagliptin—Infection—Metformin—polycystic ovary syndrome	0.000566	0.0101	CcSEcCtD
Sitagliptin—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000559	0.00993	CcSEcCtD
Sitagliptin—Skin disorder—Metformin—polycystic ovary syndrome	0.000554	0.00983	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000519	0.00922	CcSEcCtD
Sitagliptin—CYP2C8—endometrium—polycystic ovary syndrome	0.000515	0.0384	CbGeAlD
Sitagliptin—Somnolence—Metformin—polycystic ovary syndrome	0.000507	0.009	CcSEcCtD
Sitagliptin—Dyspepsia—Metformin—polycystic ovary syndrome	0.000502	0.00891	CcSEcCtD
Sitagliptin—Decreased appetite—Metformin—polycystic ovary syndrome	0.000495	0.0088	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000492	0.00874	CcSEcCtD
Sitagliptin—Fatigue—Metformin—polycystic ovary syndrome	0.000491	0.00873	CcSEcCtD
Sitagliptin—Constipation—Metformin—polycystic ovary syndrome	0.000487	0.00866	CcSEcCtD
Sitagliptin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00047	0.00834	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000466	0.00828	CcSEcCtD
Sitagliptin—CYP2C8—pituitary gland—polycystic ovary syndrome	0.000466	0.0347	CbGeAlD
Sitagliptin—DPP4—Peptide hormone metabolism—GHRL—polycystic ovary syndrome	0.000464	0.0178	CbGpPWpGaD
Sitagliptin—Urticaria—Metformin—polycystic ovary syndrome	0.000453	0.00804	CcSEcCtD
Sitagliptin—Abdominal pain—Metformin—polycystic ovary syndrome	0.000451	0.008	CcSEcCtD
Sitagliptin—DPP4—Peptide hormone metabolism—ACE—polycystic ovary syndrome	0.000449	0.0172	CbGpPWpGaD
Sitagliptin—DPP4—Peptide hormone metabolism—TCF7L2—polycystic ovary syndrome	0.000431	0.0165	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—BCL11A—polycystic ovary syndrome	0.000428	0.0164	CbGpPWpGaD
Sitagliptin—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—polycystic ovary syndrome	0.000411	0.0157	CbGpPWpGaD
Sitagliptin—Asthenia—Metformin—polycystic ovary syndrome	0.000409	0.00726	CcSEcCtD
Sitagliptin—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—polycystic ovary syndrome	0.000407	0.0156	CbGpPWpGaD
Sitagliptin—Diarrhoea—Metformin—polycystic ovary syndrome	0.00039	0.00693	CcSEcCtD
Sitagliptin—CYP2C8—vagina—polycystic ovary syndrome	0.000386	0.0287	CbGeAlD
Sitagliptin—Dizziness—Metformin—polycystic ovary syndrome	0.000377	0.00669	CcSEcCtD
Sitagliptin—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—polycystic ovary syndrome	0.00037	0.0142	CbGpPWpGaD
Sitagliptin—ABCB1—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.000369	0.0141	CbGpPWpGaD
Sitagliptin—Vomiting—Metformin—polycystic ovary syndrome	0.000362	0.00644	CcSEcCtD
Sitagliptin—CYP2C8—endocrine gland—polycystic ovary syndrome	0.000361	0.0269	CbGeAlD
Sitagliptin—Rash—Metformin—polycystic ovary syndrome	0.000359	0.00638	CcSEcCtD
Sitagliptin—Dermatitis—Metformin—polycystic ovary syndrome	0.000359	0.00638	CcSEcCtD
Sitagliptin—CYP2C8—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000358	0.0137	CbGpPWpGaD
Sitagliptin—Headache—Metformin—polycystic ovary syndrome	0.000357	0.00634	CcSEcCtD
Sitagliptin—Nausea—Metformin—polycystic ovary syndrome	0.000339	0.00601	CcSEcCtD
Sitagliptin—ABCB1—embryo—polycystic ovary syndrome	0.000337	0.0251	CbGeAlD
Sitagliptin—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—polycystic ovary syndrome	0.000317	0.0121	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—CGB5—polycystic ovary syndrome	0.000312	0.012	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—MANEA—polycystic ovary syndrome	0.000286	0.0109	CbGpPWpGaD
Sitagliptin—DPP4—Peptide hormone metabolism—LEP—polycystic ovary syndrome	0.000279	0.0107	CbGpPWpGaD
Sitagliptin—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000276	0.0206	CbGeAlD
Sitagliptin—ABCB1—endometrium—polycystic ovary syndrome	0.000247	0.0184	CbGeAlD
Sitagliptin—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000244	0.0182	CbGeAlD
Sitagliptin—DPP4—Peptide hormone metabolism—POMC—polycystic ovary syndrome	0.00024	0.00918	CbGpPWpGaD
Sitagliptin—DPP4—Peptide hormone metabolism—INS—polycystic ovary syndrome	0.000238	0.00913	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—ADAMTS7—polycystic ovary syndrome	0.000237	0.00906	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—CPB2—polycystic ovary syndrome	0.000237	0.00906	CbGpPWpGaD
Sitagliptin—DPP4—Peptide hormone metabolism—IGF1—polycystic ovary syndrome	0.000231	0.00883	CbGpPWpGaD
Sitagliptin—ABCB1—uterus—polycystic ovary syndrome	0.000227	0.0169	CbGeAlD
Sitagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.000227	0.00871	CbGpPWpGaD
Sitagliptin—ABCB1—pituitary gland—polycystic ovary syndrome	0.000223	0.0166	CbGeAlD
Sitagliptin—ABCB1—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000223	0.00852	CbGpPWpGaD
Sitagliptin—ABCB1—adipose tissue—polycystic ovary syndrome	0.000222	0.0166	CbGeAlD
Sitagliptin—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—polycystic ovary syndrome	0.000208	0.00797	CbGpPWpGaD
Sitagliptin—ABCB1—adrenal gland—polycystic ovary syndrome	0.0002	0.0149	CbGeAlD
Sitagliptin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—polycystic ovary syndrome	0.000199	0.00761	CbGpPWpGaD
Sitagliptin—CYP2C8—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000195	0.00748	CbGpPWpGaD
Sitagliptin—CYP3A4—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000192	0.00736	CbGpPWpGaD
Sitagliptin—CYP2C8—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000188	0.0072	CbGpPWpGaD
Sitagliptin—ABCB1—female gonad—polycystic ovary syndrome	0.000186	0.0139	CbGeAlD
Sitagliptin—ABCB1—vagina—polycystic ovary syndrome	0.000185	0.0138	CbGeAlD
Sitagliptin—DPP4—Metabolism of proteins—INHBB—polycystic ovary syndrome	0.000179	0.00686	CbGpPWpGaD
Sitagliptin—ABCB1—endocrine gland—polycystic ovary syndrome	0.000173	0.0129	CbGeAlD
Sitagliptin—DPP4—Metabolism of proteins—RPL37A—polycystic ovary syndrome	0.000161	0.00616	CbGpPWpGaD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.00015	0.00573	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB1—polycystic ovary syndrome	0.000146	0.00558	CbGpPWpGaD
Sitagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000137	0.00525	CbGpPWpGaD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000137	0.00524	CbGpPWpGaD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000135	0.00517	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—LHB—polycystic ovary syndrome	0.000133	0.00508	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000128	0.00491	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—polycystic ovary syndrome	0.000128	0.0049	CbGpPWpGaD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000127	0.00487	CbGpPWpGaD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000126	0.00481	CbGpPWpGaD
Sitagliptin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000125	0.0048	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.000119	0.00454	CbGpPWpGaD
Sitagliptin—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.000114	0.00437	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—FOXP3—polycystic ovary syndrome	0.000112	0.00428	CbGpPWpGaD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000111	0.00425	CbGpPWpGaD
Sitagliptin—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000105	0.00402	CbGpPWpGaD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000103	0.00395	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—TFRC—polycystic ovary syndrome	0.000102	0.00389	CbGpPWpGaD
Sitagliptin—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000101	0.00386	CbGpPWpGaD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000101	0.00386	CbGpPWpGaD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	9.94e-05	0.00381	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—LMNA—polycystic ovary syndrome	9.82e-05	0.00376	CbGpPWpGaD
Sitagliptin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	9.7e-05	0.00371	CbGpPWpGaD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	9.39e-05	0.0036	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—GHRL—polycystic ovary syndrome	8.76e-05	0.00335	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—ACE—polycystic ovary syndrome	8.48e-05	0.00325	CbGpPWpGaD
Sitagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	8.42e-05	0.00322	CbGpPWpGaD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	8.16e-05	0.00313	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	8.15e-05	0.00312	CbGpPWpGaD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	8.12e-05	0.00311	CbGpPWpGaD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	8.01e-05	0.00307	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	7.35e-05	0.00281	CbGpPWpGaD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	7.25e-05	0.00278	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	7.13e-05	0.00273	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	6.88e-05	0.00263	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	6.83e-05	0.00262	CbGpPWpGaD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	6.74e-05	0.00258	CbGpPWpGaD
Sitagliptin—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	6.69e-05	0.00256	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—SULT2A1—polycystic ovary syndrome	6.65e-05	0.00255	CbGpPWpGaD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	6.58e-05	0.00252	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	6.56e-05	0.00251	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	6.42e-05	0.00246	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	6.31e-05	0.00242	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	6.27e-05	0.0024	CbGpPWpGaD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	6.05e-05	0.00232	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	5.96e-05	0.00228	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—CYP11A1—polycystic ovary syndrome	5.89e-05	0.00226	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	5.81e-05	0.00223	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—LEP—polycystic ovary syndrome	5.69e-05	0.00218	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	5.54e-05	0.00212	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	5.49e-05	0.0021	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—CYP17A1—polycystic ovary syndrome	5.48e-05	0.0021	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	5.41e-05	0.00207	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	5.4e-05	0.00207	CbGpPWpGaD
Sitagliptin—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	5.39e-05	0.00206	CbGpPWpGaD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	5.33e-05	0.00204	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—LEP—polycystic ovary syndrome	5.27e-05	0.00202	CbGpPWpGaD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	5.19e-05	0.00199	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	4.99e-05	0.00191	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	4.99e-05	0.00191	CbGpPWpGaD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	4.91e-05	0.00188	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	4.57e-05	0.00175	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—POMC—polycystic ovary syndrome	4.53e-05	0.00173	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—INS—polycystic ovary syndrome	4.5e-05	0.00172	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	4.46e-05	0.00171	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	4.38e-05	0.00168	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	4.36e-05	0.00167	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—IGF1—polycystic ovary syndrome	4.35e-05	0.00167	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	4.35e-05	0.00166	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—CYP19A1—polycystic ovary syndrome	4.34e-05	0.00166	CbGpPWpGaD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	4.3e-05	0.00165	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	4.28e-05	0.00164	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	4.18e-05	0.0016	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	4.14e-05	0.00158	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	3.97e-05	0.00152	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	3.83e-05	0.00147	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	3.78e-05	0.00145	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	3.57e-05	0.00137	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	3.53e-05	0.00135	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	3.52e-05	0.00135	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—CYP1A1—polycystic ovary syndrome	3.5e-05	0.00134	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	3.45e-05	0.00132	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	3.38e-05	0.00129	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	3.25e-05	0.00124	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	3.22e-05	0.00123	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	3.16e-05	0.00121	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	3.12e-05	0.00119	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NMNAT3—polycystic ovary syndrome	3.07e-05	0.00118	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	3.07e-05	0.00118	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	2.95e-05	0.00113	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	2.94e-05	0.00113	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	2.93e-05	0.00112	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	2.9e-05	0.00111	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	2.88e-05	0.0011	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	2.87e-05	0.0011	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—LPCAT2—polycystic ovary syndrome	2.81e-05	0.00108	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SUOX—polycystic ovary syndrome	2.81e-05	0.00108	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	2.78e-05	0.00106	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	2.68e-05	0.00103	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	2.66e-05	0.00102	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	2.63e-05	0.00101	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ISYNA1—polycystic ovary syndrome	2.61e-05	0.001	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—POMC—polycystic ovary syndrome	2.61e-05	0.000998	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	2.56e-05	0.000978	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	2.45e-05	0.000938	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	2.45e-05	0.000938	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	2.39e-05	0.000913	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	2.33e-05	0.000891	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	2.3e-05	0.000879	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	2.28e-05	0.000872	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	2.26e-05	0.000867	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—TEAD2—polycystic ovary syndrome	2.22e-05	0.000851	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—AKR1C2—polycystic ovary syndrome	2.22e-05	0.000851	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	2.14e-05	0.000818	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	2.1e-05	0.000806	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	2.01e-05	0.000769	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	1.94e-05	0.000742	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	1.94e-05	0.000742	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	1.88e-05	0.000718	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PNPLA2—polycystic ovary syndrome	1.86e-05	0.000713	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	1.85e-05	0.000709	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	1.77e-05	0.000676	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	1.75e-05	0.000671	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	1.73e-05	0.000661	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	1.68e-05	0.000645	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.67e-05	0.000638	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	1.65e-05	0.000632	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	1.62e-05	0.000621	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	1.6e-05	0.000614	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	1.54e-05	0.000589	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	1.51e-05	0.000578	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	1.51e-05	0.000578	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	1.5e-05	0.000575	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—STAR—polycystic ovary syndrome	1.47e-05	0.000562	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.47e-05	0.000562	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	1.43e-05	0.000548	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.42e-05	0.000542	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	1.4e-05	0.000537	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	1.4e-05	0.000536	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.34e-05	0.000514	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	1.31e-05	0.000502	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	1.31e-05	0.000501	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	1.31e-05	0.0005	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	1.28e-05	0.000489	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	1.25e-05	0.000478	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	1.24e-05	0.000473	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.23e-05	0.000471	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	1.19e-05	0.000457	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	1.19e-05	0.000457	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—LHB—polycystic ovary syndrome	1.14e-05	0.000436	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	1.14e-05	0.000436	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	1.11e-05	0.000426	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	1.1e-05	0.000422	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	1.08e-05	0.000412	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	1.06e-05	0.000407	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	1.02e-05	0.000391	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.01e-05	0.000389	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	1.01e-05	0.000386	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1e-05	0.000383	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1e-05	0.000383	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	9.91e-06	0.00038	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	9.6e-06	0.000368	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	9.52e-06	0.000364	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	9.48e-06	0.000363	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	9.37e-06	0.000359	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	9.26e-06	0.000354	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	9.04e-06	0.000346	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	8.89e-06	0.00034	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	8.78e-06	0.000336	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	8.29e-06	0.000318	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	8.16e-06	0.000313	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—TH—polycystic ovary syndrome	8.11e-06	0.00031	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	8.06e-06	0.000309	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	7.89e-06	0.000302	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	7.69e-06	0.000294	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	7.42e-06	0.000284	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—TH—polycystic ovary syndrome	7.06e-06	0.00027	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	7.01e-06	0.000268	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	6.87e-06	0.000263	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	6.85e-06	0.000262	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	6.64e-06	0.000254	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	6.62e-06	0.000253	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	6.46e-06	0.000247	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	6.31e-06	0.000241	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	6.11e-06	0.000234	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	5.98e-06	0.000229	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	5.92e-06	0.000227	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	5.77e-06	0.000221	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	5.7e-06	0.000218	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	5.57e-06	0.000213	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	5.49e-06	0.00021	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	5.48e-06	0.00021	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	5.41e-06	0.000207	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	5.21e-06	0.000199	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	5.11e-06	0.000196	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	5.03e-06	0.000193	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	4.86e-06	0.000186	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	4.52e-06	0.000173	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	4.46e-06	0.000171	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—INS—polycystic ovary syndrome	4.43e-06	0.00017	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—TH—polycystic ovary syndrome	4.35e-06	0.000167	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.23e-06	0.000162	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.98e-06	0.000152	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	3.94e-06	0.000151	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—POMC—polycystic ovary syndrome	3.88e-06	0.000149	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—INS—polycystic ovary syndrome	3.86e-06	0.000148	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.55e-06	0.000136	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.38e-06	0.00013	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.21e-06	0.000123	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.99e-06	0.000115	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.43e-06	9.29e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.39e-06	9.16e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.38e-06	9.11e-05	CbGpPWpGaD
